0001415889-24-003811.txt : 20240214 0001415889-24-003811.hdr.sgml : 20240214 20240214183648 ACCESSION NUMBER: 0001415889-24-003811 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240212 FILED AS OF DATE: 20240214 DATE AS OF CHANGE: 20240214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stevens Jennifer CENTRAL INDEX KEY: 0001982621 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39813 FILM NUMBER: 24641277 MAIL ADDRESS: STREET 1: C/O TRISALUS LIFE SCIENCES, INC. STREET 2: 6272 W. 91ST AVENUE CITY: WESTMINSTER STATE: CO ZIP: 80031 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TriSalus Life Sciences, Inc. CENTRAL INDEX KEY: 0001826667 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 853009869 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6272 WEST 91ST AVENUE CITY: WESTMINSTER STATE: CO ZIP: 80031 BUSINESS PHONE: 415 336 8917 MAIL ADDRESS: STREET 1: 6272 WEST 91ST AVENUE CITY: WESTMINSTER STATE: CO ZIP: 80031 FORMER COMPANY: FORMER CONFORMED NAME: MedTech Acquisition Corp DATE OF NAME CHANGE: 20200930 4 1 form4-02142024_110203.xml X0508 4 2024-02-12 0001826667 TriSalus Life Sciences, Inc. TLSI 0001982621 Stevens Jennifer 6272 W. 91ST AVENUE WESTMINSTER CO 80031 false true false false CHIEF REGULATORY OFFICER 0 Common Stock 2024-02-12 4 A 0 14752 0 A 32783 D Employee Stock Option (right to buy) 9.50 2024-02-12 4 A 0 63750 0 A 2034-02-11 Common Stock 63750 63750 D Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU Award vest in four equal annual installments commencing on February 12, 2024, subject to the Reporting Person's continued service with the Issuer on each respective vesting date. One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of February 12, 2024, and 1/36th of the remaining shares shall vest each month thereafter, subject to the Reporting Person's continued service with the Issuer on each respective vesting date. /s/ Sean Murphy, Attorney-in-Fact 2024-02-14